Circio: circRNA poster to be presented at the ASGCT Annual Meeting
Oslo, Norway, 3 May 2023 – Circio Holding ASA (formerly Targovax ASA*) (OSE: TRVX) today announces that an abstract describing its circular RNA platform has been accepted for poster presentation at the 2023 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting in Los Angeles, USA. The abstract describes the development of Circio’s proprietary circAde vector system for therapeutic protein expression. Key elements necessary for circRNA biogenesis were systematically screened and optimized to facilitate high yield circRNA expression. Additionally, protein expression from the